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Abstract
Background: From 2019 to 2021, there has been an increase in opioid prescribing, leading to
the current death rate of 136 Americans per day from an opioid overdose (Centers for Disease
Control and Prevention [CDC], 2021). In response to these shocking statistics, a Veterans
Administration (VA) health care system initiated a face-to-face interdisciplinary opioid safety
shared medical appointment (SMA). Although the face-to-face Opioid Safety SMA was
successful in increasing opioid safety awareness, participation, and attendance for the SMA
have declined over the last year.
Purpose: The purpose of the DNP project was to improve attendance for veterans
participating in the Opioid Safety SMA within a VA health care system in 60 days thus
increasing opioid safety awareness.
Methods: To improve attendance throughout the five-session SMA currently being
completed face-to-face, a virtual SMA (VSMA) was implemented. Outcomes were measured
by comparing attendance for all virtual sessions to past practice attendance results.
Results: The outcome data from chart reviews, pre- and post-VSMA implementation, reveal
that a VSMA is statistically significant in improving the average percentage of attendance,
average number of participants per session, and average sessions received per patient
compared to the face-to-face Opioid Safety SMA.
Conclusion:. Increasing patients' access to the opioid safety SMA via a virtual platform and
the tools necessary to participate increased attendance and participation in the evidence-based
patient education program.

Keywords: opioids, opioid epidemic, shared medical appointment, group visit,
telemedicine, virtual, VSMA, SMA
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The Effectiveness of a Virtual Shared Medical Appointment on Opioid Safety Education
Participation in the Veteran Population within a VA Health Care System
The opioid epidemic is a global and national crisis that demands attention from health
care providers and policymakers. From 2019 to 2021, an increase in opioid prescribing has
led to the current death rate of 136 Americans per day from an opioid overdose (Centers for
Disease Control and Prevention [CDC], 2021). In 2019, 70,630 American deaths involved an
opioid (CDC, 2021). The White House (2017) called to action the need for community
education on opioid safety. In 2020, in response to these statistics and needs, a Veterans
Administration (VA) health care facility successfully initiated a face-to-face interdisciplinary
opioid safety shared medical appointment (SMA). After declining attendance over the last
year, this DNP project aimed to increase accessibility to the Opioid Safety SMA utilizing a
virtual platform.
Background
National Statistics
In 2017, Human Health Services (HHS) declared the opioid epidemic a public
emergency. To further explain the magnitude of the problem, 91 Americans a day and over
500,000 individuals have lost their lives in the past 20 years due to an opioid-related overdose
(HHS, 2021). In 2020, Americans diagnosed with opioid use disorder (OUD) rose to 1.6
million (HHS, 2021). In addition to the cost of human lives, the cost of the opioid epidemic
has greatly affected our nation. In 2017, it was estimated that the treatment of the U. S. opioid
epidemic cost over one trillion dollars, including costs of OUD and opioid overdose treatment
(Kuehn, 2021). With one in three Medicare Part D beneficiaries receiving an opioid
prescription, inappropriate prescribing of opioids is one of the leading causes of the opioid
crisis (HHS, 2021). The statistics reveal a concerning issue that has detrimental effects on our
population but has even more significant consequences for the veteran population.
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Effect on Veterans
Veterans are at an increased risk for OUD and overdose. The VA Office of Research
and Development (ORD) (2021) noted over two million veterans have a chronic pain
diagnosis, and one-third of those are prescribed an opioid for treatment. Twenty-four percent
of veterans are prescribed controlled substances to treat this pain, and 12% are prescribed
opioids (ORD, 2021). Fifty percent of those veterans age 65 and older experience chronic
pain, making them the most at risk for chronic opioid dependency (ORD, 2021). In addition,
veterans are twice as likely to die from an accidental overdose compared to non-veterans
(ORD, 2021). Due to the severe consequences of opioid prescribing in the veteran population,
alternative methods for chronic pain need exploration.
Social Determinants
The role of social and economic health determinants for veterans in the opioid crisis
creates a need for a complex and interdisciplinary solution. Communities whose populations
are economically unstable and have a high unemployment rate have a higher rate of OUD,
addiction, and opioid overdose (Bohler et al., 2021). In addition, education directly correlates
with increased employment opportunities, and people with higher education levels have a
decreased rate of opioid overdose deaths. The National Center for Veterans Analysis and
Statistics (NCVAS) (2019), found that 19% of veterans have an annual income of less than
$20,000 and only 35% have some college education (NCVAS, 2019).
Like many chronic diseases, communities with limited access to proper food and
nutrition, poor housing conditions, and limited access to medical treatment have poor health
outcomes (Bohler et al., 2021). In 2018, the Housing and Urban Development (HUD)
Exchange determined that there are 37,878 homeless veterans. These veterans are at an
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increased risk for substance misuse, including opioid use, and have limited access to
transportation and health care (ORD, 2021).
National Strategies
Under President Trump, national strategies proposed by HHS and CDC focused on
improving access to prevention and treatment, distribution of reversal agents such as
naloxone, increasing public awareness, improving public health data reporting, and sharing,
and advancing research and practice of addiction and pain (HHS, 2021). Almost $900
million in grants and funding were approved in 2020 by Congress to assist state and local
governments (HHS, 2021). Specifically, the National Institutes of Health (NIH) Helping to
End Addiction Long-term (HEAL) Initiative was approved to research innovative solutions to
the national opioid overdose crisis (NIDA, 2020). New initiatives and the national strategies
mentioned demonstrate the severity of this epidemic.
Opioid Safety Shared Medical Appointment
In response to the opioid epidemic and its impact on the veteran population, a local
VA Health Care System formed an interdisciplinary team to determine a solution for VA
patients. The solution was an opioid safety SMA, a five-session interdisciplinary appointment
that includes nurses, dieticians, pharmacists, providers, social workers, and psychologists.
The curriculum utilized throughout the sessions included opioid statistics, opioid reversal
agents, opioid side effects and risks, opioid dependence and withdrawal, and opioid tapering
and alternative treatments. In addition to opioid safety, the patients received health coaching,
created a personal health plan, a pain care plan, and learned a complementary health exercise
at each session. The exercises included mindfulness, tai chi, yoga, and guided imagery.
Specialists were brought in to discuss how pain can affect sleep, diet, emotions, and mood
and various interventions to improve quality of life with a diagnosis of pain. Per the Whole
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Health Opioid Safety Committee data collection, the Opioid Safety SMA successfully
reduced Morphine Equivalent Daily Dose (MEDD) by 21%, increased knowledge regarding
opioid safety by over 45%, and decreased pain scores over 12 months by 29%.
Needs Analysis
Although the face-to-face Opioid Safety SMA was considered an overall success,
participation, and attendance for the five-session SMA have declined by 44% in sessions 3-4
and 49% by session 5 (three cohorts of 15 patients). A strengths, weaknesses, opportunities,
and threats (SWOT) analysis was completed to assess current internal strengths and
weaknesses, and external opportunities and threats. Internal strengths include that the current
SMA has proven successful in decreasing opioid reliance. In addition, it determined that an
interdisciplinary team is a robust approach that assists in addressing many issues related to
pain and ultimately patients are satisfied. Internal weaknesses include space limitation,
patient attendance, the time commitment for patients and providers, and buy-in from patients
and leadership. After further assessment, barriers to attendance included transportation, cost
of travel, and lack of time. External opportunities include making this successful program
more accessible to other patients and patients throughout the VA utilizing a virtual shared
medical appointment (VSMA). External threats include voluntary attendance and buy-in from
patients and leadership to change the conversation and use new techniques to treat pain.
Problem Statement
The Opioid Safety SMA has proven successful in treating OUD. Continuous
attendance and participation in the five-session SMA are vital to improved veterans’ health
outcomes. Attendance to the Opioid Safety SMA addresses opioid knowledge deficiencies
and increases population knowledge of opioid safety practices and alternative pain treatments.
This could ultimately lead to a decrease in opioid overdose among veterans. The PICOT
question utilized in this DNP project is: for veterans who are participating in the Opioid
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Safety shared medical appointment (SMA) at a VA Health Care System (P), what is the effect
of an interdisciplinary virtual shared medical appointment (VSMA) (I) compared to a face-toface interdisciplinary SMA (C) on attendance (O) in 60 days (t)?
Aims and Objectives
The overarching aim of this DNP project is to increase participation and attendance to
the Opioid Safety SMA at a VA Health Care system in 60 days. To accomplish this aim, the
delivery of the curriculum was modified to consider the new virtual format. This aim will
increase opioid safety awareness and could potentially lead to decreased incidence of opioid
overdose.
Review of Literature
Search Methodology
A literature review was performed to support this project utilizing the following dates:
January 2015 to February 2022. Fifty-six articles were reviewed to ensure the most relevant
evidence. The search revealed 28 randomized controlled trials (RCT) but currently no
systematic reviews specific to VSMAs were found; however, there were systematic reviews
related to face-to-face SMAs. The author believes this is due to the concept of VSMAs being
a relatively new technique versus face-to-face models. The inclusion criteria included fulltext articles published in English from 2015 to 2022 and from a peer-review journal. The
search generated 18 studies. These studies included research, non-research, and a few
editorials that supported the author’s project with additional evidence and data. After a
thorough appraisal of evidence, articles were selected based on the strength of evidence and
relevance to the topic. Numerous databases were searched to acquire ample evidence,
including Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed,
and Cochrane Library. The search used the following keywords: opioids, telemedicine, virtual

13

shared medical appointments, virtual group appointments, attendance, participation, and noshow rates.
Summary of Evidence
Evidence reviewed (Appendix A) concludes that SMAs or group visits successfully
improve health outcomes in many chronic diseases, including chronic pain (Wadsworth et al.,
2019). SMAs improve patient-provider relationships, patient trust, quality of care, quality of
life, and clinical parameters reviewed. Specifically, with veterans and opioid usage,
Romanelli et al. completed a study that concluded increased confidence levels of veterans
who attended an opioid SMA on managing and treating their pain and decreased reported
opioid use (2017). Although the evidence shows the success of SMAs, Wadsworth, et al.
(2019) completed a systematic review of 26 studies utilizing face-to-face SMAs to treat
chronic diseases that noted attendance and participation as a barrier. Integrating the virtual
platform could potentially increase accessibility and attendance.
Ramdas and Swaminathan (2021), with the Cleveland Clinic, reported that during a
time of decreased access to care and a provider shortage, alternative health care delivery
systems, such as VSMAs, are critical in providing care to underprivileged and rural
populations. The authors also cited that VSMAs increase patient self-care, compliance with
medications, and engagement with health care.
Several smaller studies revealed relevant findings to the DNP Project. A study
completed on young cancer patients receiving group psychotherapy, in-person and virtual
appointments indicated that lower attrition rates were noted with the VSMA, ultimately
leading to higher satisfaction rates among patients (Melton et al., 2017). In addition, a study
completed on utilizing telemedicine to deliver a group intensive outpatient service with a
large sample of 869 patients saw an improvement of attendance in their adult and adolescent
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population. Considering other factors besides attendance, a cohort study by Reid et al. (2018)
concluded that implementing a VSMA for Type 1 Diabetes led to high engagement,
satisfaction, and improved peer support and relationships with the health care team.
Increasing accessibility to health care is of top priority, especially considering the
current pandemic. In response, Patel et al. (2020) completed a feasibility and acceptability
study on utilizing telemedicine for group visit provider encounters. Post-survey results
showed that “participants (N=19) found telemedicine useful and easy to use (4.9/5.0, 4.4/5.0,
respectively) and with excellent interface (4.3/5.0), interaction (4.6/5.0), reliability (4.2/5.0),
and satisfaction (4.4/5.0)” (Patel et al., 2020, p. 1). In addition, the clinical improvements
from the in-person group visits compared to the virtual group visits did not show a significant
difference. Despite the small sample size, the study concluded that utilizing telemedicine in
group visits is feasible, acceptable, and improves access to care.
Theoretical Model
Rosemarie Rizzo Parse’s Human Becoming Theory (2016) guides the practice of
nurses to focus on quality of life as it is described and lived. Parse’s model, outlined in
Appendix B, rates quality of life from each person’s perspective as the goal of the nursing
practice (Parse, 2016). The model gives the nurse the ability to see the patient’s perspective.
This allows the nurse to be ‘with’ the patient and guide them toward health goals (Parse,
2016). Patients with a diagnosis of opioid use disorder must be placed at the center of their
health. Evidence shows patient outcomes are more successful when the patient is involved in
health care decisions (Parse, 2016). Utilizing a patient-centered care approach in treating
opioid use disorder will yield better outcomes. This theoretical model gives control to the
patient to guide their health care. Utilizing the Human Becoming theory when implementing
strategies to treat opioid use disorder will allow patients to use self-perspective and quality of
life when considering this life change.
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Methodology
This project was developed to increase accessibility to crucial opioid safety education
for opioid use disorder. The primary intervention of this project was to implement an Opioid
Safety VSMA instead of the current face-to-face Opioid Safety SMA. The hypothesis of this
study was that the Opioid Safety VSMA would increase attendance compared to the face-toface SMA. The literature has been reviewed and referenced for evidence to successfully
implement this practice change.
Patients identified by their provider as being prescribed opioids for greater than 3
months were offered a recruitment flyer and received a follow-up call by a clerk to create
appointments if interested. They were asked the following questions to determine if they were
eligible: Can you participate in technology training? Do you have the ability to operate
technology? Are you willing to participate in the virtual setting? If they answered yes to the
above three questions, they were enrolled in the Opioid Safety VSMA.
Setting
The virtual appointments were held for an urban VA hospital for patients in primary
care (PC) in Alabama. There are three primary clinics at this facility: gold, red, and blue
providing active care to 32,591 patients. These patients are seen for a variety of chronic
conditions and preventative care. On average, together these clinics see approximately 108
patients daily.
To conduct the VSMA, a virtual appointment was hosted on VA Video Connect, a
virtual platform. Patients could utilize a mobile device, computer, or tablet to access the
appointment from a place of comfort. Patients without a mobile device, computer, tablet,
and/or WIFI access could opt-in to utilize a VA-loaned tablet. This tablet would be mailed to
the patient’s home along with troubleshooting instructions and a user’s manual. The tablets
have built-in Wi-Fi or 4G mobile data connectivity and pre-paid access to a national wireless
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provider’s data secure network. The tablets were limited to video communication and were
loaded with videoconferencing software. The tablets did not allow for other connectivity
outside of the VA Video appointments, such as outside internet access or phone calls.
Tablets were loaned out to the patient for the duration of the VSMA. At the end of the
VSMA, the patient had 14-days to return the tablet utilizing the pre-paid shipping box sent to
their home mailing address. Once returned, the tablets were disinfected by the local telehealth
office. Only seven out of the 45 patients opted in to utilize a tablet. Of the seven that were
utilized, five have currently been returned to the facility. The other two tablets are pending
return.
Population
The target population were patients currently enrolled in the VA health care system
who are prescribed opioids for greater than 3 months. Overall, 98 participants were referred
by their providers to this program. Forty-five patients participated in the study, 22 opted to
participate in the face-to-face SMA instead of the VSMA, and 31 patients opted not to
participate in either version of the SMA. Due to the success of smaller groups in the face-toface SMA, the 45 patients who participated in the VSMA were randomly divided into three
cohorts.
Inclusion/Exclusion Criteria for Patients
Inclusion criteria included patients of the local VA health care system prescribed
opioids for greater than 3 months, could participate in technology training, had the ability to
operate technology, and were willing to participate in the virtual setting. Exclusion criteria
included those that were not prescribed opioids or prescribed opioids for less than 3 months,
patients outside of the local VA health care system, and patients who were unwilling or
unable to operate technology or attend and participate in training. Local VA patients who
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were excluded continued with face-to-face SMA sessions but were not included in project
data.
Recruitment
Patients prescribed opioids greater than 3 months were asked by their primary care
provider to attend the Opioid Safety SMA via a virtual platform. Patients who met the above
criteria received a recruitment flyer and a phone call from the clerk to schedule their
appointments. Participants were notified that the Opioid Safety VSMA was voluntary.
Consent
Prior to project participation, consent was obtained from all project participants
(Appendix C). Participants were informed that participation in the quality improvement (QI)
project was voluntary and of the process to stop participating at any point throughout the
project. Participants were also notified that the sessions would not be recorded, although the
appointment was virtual. Due to the limitations of confidentiality in a group appointment,
specific ground rules were outlined in the consent. The ground rules were as follows:
•

Participants were only required to share what they felt comfortable sharing

•

Providers would not call on any patient for information. Patients would only share if
they were willing and wanted to volunteer the information.

•

Privacy and Confidentiality of the conversations that occurred during the VSMA did
not leave the room of the VSMA

•

All participants and providers would let participants share without unnecessary
interruption
Design
Education regarding the virtual platform and equipment was provided before the

sessions to ensure a successful virtual SMA. Participating veterans were mailed a kit that
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included informed consent with a return envelope, the Opioid Safety SMA workbook, and
detailed instructions on downloading and using VA Video Connect. If the participants
notified the provider that they did not have the proper equipment or WIFI, they could opt-in
to be provided a WIFI-enabled tablet with a hot spot for the duration of the VSMA. Prior to
their appointment, participants were contacted as a reminder of their scheduled appointment.
Participants also completed a tutorial on their equipment and the use of the virtual platform
before their appointment. Once the VSMA was completed, the patients were required to
return the tablets via a prepaid shipping box.
Framework
The Mobilize-Assess-Plan-Implement-Track (MAP-IT) framework was utilized to
assess the interventions in this project for effectiveness. This framework was developed to
assist communities in solving local health issues and developing community-wide health
initiatives. The MAP-IT framework (Appendix D) prioritizes collaboration and building
coalitions to improve health. Utilizing this framework assisted the author in outlining and
organizing all objectives and strategies in the implementation of the Opioid Safety VSMA.
The MAP-IT process started with gaining buy-in from the medical center leaders, who
ensured a smooth and efficient process throughout the DNP project.
Risk and Benefits
The risk for patients was minimal for this DNP project and primarily centered around
confidentiality. Risks were mitigated by breakout rooms for virtual patients who needed to
speak privately with their providers which assisted in protecting privacy. In addition, creating
and ensuring ground rules were enforced made participants feel safe sharing. The QI project
adhered to all ethical standards to protect all patients involved.
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The benefit of establishing a technique to disseminate opioid safety education
outweighs the minimal risk. Community outreach and the opportunity to further educate
patients on opioid safety could decrease the rate of opioid overdose and misuse.
Compensation
Participation in the study was completely voluntary and no compensation was
provided to the patients.
Timeline
The project spanned 13 months, beginning in June 2021 and ending in July 2022 (see
Appendix E). The timeline consisted of three phases: planning, implementation, and
dissemination. Project preparation and planning occurred over six months and included
gaining agency support, receiving Proposal Evaluation Review Committee (PERC) approval,
completion of Collaborative Institutional Training Initiative (CITI) training (Appendix F),
and obtaining approval from the relevant Institutional Review Board (IRB) (Appendix G).
The implementation phase (January 2022-May 2022) consisted of project implementation,
data collection, data analysis, and manuscript composition. The dissemination phase
consisted of the final DNP Project presentation to end the timeline.
Budget and Resources
The resources utilized in this project include all members of the interdisciplinary team
and the mailing and printing of materials. The DNP project reveals a cost savings of over
$5,000 associated with the use of VSMAs over face-to-face SMAs. The budget and resources
utilized in this DNP project are summarized in Appendix H.
Evaluation Plan
Chart reviews were completed to collect attendance from three cohorts that
participated in the Opioid Safety SMA via face-to-face from February to April 2021. This
data was compared to the attendance collected from three cohorts that completed the Opioid
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Safety VSMA from February to April 2022. The outcomes collected from both virtual and
face-to-face sessions were compared via the attendance tracking sheet (Appendix I). It is
important to note that participation was voluntary, and the Opioid Safety SMA was not a
requirement currently to continue opioid therapy.
Statistical Considerations
Descriptive statistics were performed to analyze each participant’s average and
frequency of attendance. Utilizing excel, a two-tailed independent t-test was performed to
ascertain a statistical difference between the two groups, face-to-face and virtual.
Data Maintenance & Security
All efforts were made to keep personal information in the research record
confidential. Only a randomized ID code was utilized without any other personal identifiers
on the excel spreadsheet where attendance was recorded. Attendance records remained
double locked (in a locked file cabinet within a locked room) within the medical facility, and
information was not removed from the premises until all identifiable information was
removed. Data from the past attendance records and chart reviews were recorded similarly.
After all aspects of the project were completed and the IRB was closed, all data was
destroyed and disposed of per university and VA policy.
Results
Thorough data analysis occurred pre-and post-implementation of the VSMA.
Variables and interventions remained consistent throughout the DNP project. Chart reviews
were completed to collect attendance from three cohorts that participated in the Opioid Safety
SMA via face-to-face from February 2021 to April 2021. This data was compared to the
attendance collected from three cohorts that completed the Opioid Safety VSMA from
February 2022 to April 2022 (see Table 1). A two-tailed, independent t-test was performed,
with an alpha of ≤ 0.05 to test for significance. Clinical significance was calculated by the
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average of SMA attendance pre- and post-VSMA implementation. The statistical data from
this project are summarized in Table 2 and depicted via a graph in Figure 1.
Pre-implementation Results
The review of 45 charts established that the attendance of participants in the face-toface Opioid Safety SMA varied from February to April 2021. An average of 9.47 participants
attended each session of the face-to-face SMA and the average number of sessions attended
per participant was 3.16. The average percentage of attendance across all three cohorts was
57.33%. It is important to note a consistently decreasing trend of attendance across the
sessions. Forty-five patients were enrolled in the three face-to-face SMAs. In session 1, 35 of
the 45 patients were present. By session 2, a total of 32 patients were in attendance and 27 in
attendance for session 3. The two concluding sessions 4 and 5, had 23 and 25 patients,
respectively.
Post-Implementation Results
The review of 45 charts following implementation of the Opioid Safety VSMA from
February 2022 to April 2022 showed an average of 12.27 participants attended each session
of the VSMA and the average number of sessions attended per participant was 4.09. The
average percentage of attendance across all three cohorts was 81.78%.
A two-tailed, independent t-test was performed, with an alpha of ≤ 0.05 to test for
significance for both average number of sessions attended per participant and the average
number of participants who attended each session. The t-test performed on the average
number of sessions attended per participant generated a p-value of 0.0001 which indicates a
clinical significance in the findings. A p-value of 0.0009 was calculated for the average
number of participants per session which also indicates clinical significance. An increase was
also noted in the average number of sessions by +0.93 attended by each patient and an overall
increase in attendance per session by an average of +2.8 patients. The average percentage of
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attendance improved from 57.33% to 81.78% ascertaining a 24.45% increase. When
examining attendance trends across the sessions of the VSMA, an improvement was noted
with sessions 2-4 remaining consistent with 37 patients after the first session of 41 of 45
patients attending. By session 5, 32 of the 45 patients were in attendance.
Table 1
Pre- and Post-Implementation Results

Cohort
Average SMA/PT
Average PT/SMA
% of Attendance

Face-to-Face
1
2
3
3.47
2.33
3.67
10.40
7.00
11.00
69.33 46.67
56

1
4.20
12.60
84

Virtual
2
3.93
11.80
78.67

3
4.13
12.40
82.67

Table 2
Statistical Analysis
Attendance
Face-to-Face
Virtual
Mean
9.47
12.27
SD
2.53
1.44
SEM
0.65
0.37
N
15
15
P value= 0.0009
α=0.05
Increase in attendance by an average of +2.8
patients

Average SMA/PT
Face-to-Face
Virtual
Mean
3.16
4.09
SD
1.22
0.9
SEM
0.18
0.13
N
45
45
P value=0.0001
α=0.05
Increase in the average # of sessions by
+0.93 attended by each patient
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Figure 1
Visual Representation of Results
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Discussion
The aim of this DNP project was to increase participation and attendance in the
Opioid Safety SMA at a VA Health Care facility over 60 days. The theoretical framework
utilized in this DNP project afforded a structure for curriculum development that is patientcentric and emphasizes self-efficacy. To accomplish this aim, the curriculum was delivered
virtually to patients meeting inclusion criteria. The outcome data from chart reviews pre- and
post-VSMA implementation suggests the DNP project aim was successfully achieved.
Significant findings of this project include a statistically significant increase in attendance and
individual SMA participation. Although the project was successful, data showed a consistent
trend of declining attendance in both the face-to-face and virtual formats as sessions progress.
This decline suggests that pertinent education should be shared in SMAs 1, 2, and 3 to ensure
the greatest number of participants receive the most significant opioid safety education.
Implications for Clinical Practice
The DNP project contributes to existing evidence to show that VSMAs are an
alternative care delivery model that increases accessibility and provides comparable
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outcomes. VSMAs have proven successful in increasing patient access to providers and
increasing the efficiency of providers in their care (Ramdas & Swaminathan, 2021). The
increased peer support provided through the SMA format allows patients with chronic
diagnoses to hold each other accountable and relate to one another’s individual experiences.
This type of care delivery model could be utilized for various chronic diseases, such as
cancer, diabetes, and/or heart disease.
Implications for Health Care Policy
The history and current state of the opioid epidemic has demanded government
attention (APHA, 2015). The widespread use and prescribing of opioids contributed to the
current opioid crisis (APHA, 2015). Current established efforts to decrease opioid reliance
focus on forced tapering that produces short-lived results and leaves patients unsatisfied
(APHA, 2015). Further funding for research, innovative strategies, and public awareness is
necessary. The advanced practice nurse must continue to advocate for policies and laws to
assist in combating this terrible epidemic.
This QI project outlines the success of alternative and innovative education regarding
opioid safety. Other facilities and insurance companies may soon mandate opioid safety
education for patients who are prescribed opioids for greater than 3 months. By mandating
this education, an emphasis will be placed on health care facilities to find innovative methods
to deliver this life-saving education to patients and prevent long-term complications, such as
opioid neurotoxicity, increased risk for fractures, clinical depression, and sleep-disordered
breathing (Baldini et al., 2012).
Implications for Quality/Safety
Birrell et al. (2020) found that VSMAs provide patients with the ability to have
increased time with their health care providers and receive peer support. Quality of care is not
compromised as it is the same care patients would receive face-to-face. It is imperative to
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ensure patients can speak to providers individually if requested. VSMA allows providers to
see 2 to 10 times more patients to provide primary and preventative care (Birrell et al., 2020).
Utilizing this care delivery model increases access to care for patients in rural areas and
addresses a looming provider shortage.
Implications for Education
Evidence and health care policy discussed previously confirm education is a key
component of preventing opioid overdose and encouraging opioid safety (APHA, 2015). The
Opioid Safety SMA was an innovative approach to providing effective education. Although it
was showing great success in increasing opioid safety awareness, a decline in attendance due
to various factors called for a change in practice. This DNP project produced clinically
significant results showing VSMAs provide an alternative process of disseminating this
innovative education. VSMAs effectively deliver education when face-to-face sessions
cannot occur or participant attendance is declining.
Limitations
Several limitations have been noted in this project and should be considered. Both
face-to-face and virtual SMAs were conducted in a single-center VA facility. Demographic
information including sex, race, and age was not collected from participants and could add
value. The participants of the VSMAs received greater support for attendance as most
received multiple forms of contact to ensure they received adequate training on the virtual
platform and equipment which may have affected the results. In addition, the limited amount
of level 1 and level 2 evidence reveals that there is a greater need for more research to be
completed on VSMAs. To increase the clinical significance of this study, there is a need for
larger cohorts, disseminating practice, and collecting data from other VA facilities that
implement VSMAs.
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An additional barrier to implementation was protected time to develop the VSMA for
all participating providers. Leadership support for protected clinical time was supported at the
start of the project but was inconsistent due to the COVID-19 pandemic and competing
priorities. Engagement in the project by both providers and patients varied.
Another limitation noted was with connectivity problems. Some of the patients that
did not opt-in to utilize the tablet, lived in rural areas and had poor broadband connection.
After the first appointment with these issues, three of the patients opted-in to receive the
tablet. Technology troubleshooting also cut into the appointment time. There was a 30-minute
time commitment for each patient at the start of each cohort who participated in the VSMA to
be educated on the virtual platform and equipment. A centralized number to receive technical
assistance is needed for success. Currently, clinical staff are completing this role.
Dissemination
Results were presented to the Whole Heath Opioid Safety Committee and the Medical
Center Director. The presentation included a cost-benefit analysis to show cost savings and
avoidance when opioid safety education is provided via a VSMA. The findings were also
presented at the university’s DNP Dissemination Conference via poster and presentation. In
addition, the DNP manuscript will be placed in the University’s Digital Commons Repository
system.
Sustainability
The virtual delivery of the Opioid Safety SMA was adopted by the health care system
and will be continued. This educational and care delivery practice will assist in improving
attendance and provide social distancing and care during the endemic. It also assists with
other barriers such as travel costs and transportation. The project will be shared regionally
throughout the Veterans Integrated Service Network (VISN) as a proposed best practice.
Greater clinical significance of the intervention can be achieved with implementation across
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multiple health care facilities and in various patient populations. This project can be
continued by future students addressing the barriers and limitations mentioned above.
Plans for Future Scholarship
This QI project identifies a new approach to delivering patient care, treatment, and
education regarding opioids; however, further research is needed to determine the
effectiveness of VSMAs. This project focused primarily on attendance, but additional studies
regarding outcomes, satisfaction, and overall feasibility would help support this evidence. In
addition, further research is needed to overcome barriers identified such as improving
confidentiality, providing technical support, and collecting data on demographics to
determine if this approach is more significant in specific groups.
Since this project only reviewed 3 months of data across two different years, longer
studies should be conducted to include hospitals in multiple locations and different
populations. A study over a larger period could reveal additional barriers and/or continued
compliance. Lastly, there is a need for more level 1 evidence to support findings and is
imperative to broad practice change.
Conclusion
The opioid epidemic is taking the lives of hundreds of U. S. citizens a day, many of
those are veterans. There is a demand for innovative methods to treat opioid use disorder and
provide opioid safety education to patients and communities. The face-to-face SMA was
proven successful with patients reporting decreased pain levels, decreased MEDD, and
increased knowledge regarding opioid safety; however, the face-to-face SMA was showing
decreased attendance and participation. The purpose of the DNP project was to improve
attendance for veterans participating in the Opioid Safety SMA utilizing a VSMA. Although
limitations were present, the project revealed statistically significant results on attendance
when using the VSMA approach. These findings help support similar results from other
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RCTs and studies. Further evidence should be completed to increase the body of research and
to examine ways to mitigate the identified barriers. Increasing patient access to opioid safety
education via VSMA could decrease opioid overdose rates, decrease complications from
long-term use of opioids, and provide a strategy to end the opioid epidemic.
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Appendix A
Table of Evidence
Article
#
1

Citation
Melton, L., Brewer, B., Kolva, E., Joshi, T., &

Evidence
Type
QI Project

Bunch, M. (2017). Increasing access to care

Sample, Sample
Size, Setting
Setting: virtualprimary Care
Sample: 8 pts
(18-40 years old,
5-206 miles
away from the
facility)

for young adults with cancer: Results of a
quality-improvement project using a novel
telemedicine approach to supportive group

Study findings that help
answer the EBP Question
Low attrition rates due to
the virtual format of SMA

Limitations

Evidence Level

Small sample
size

Level V

High engagement, increased
attendance, retention, and
satisfaction among patients.

Not randomized

Level II

Improved peer support and
relationships with the health
care team

More direct
contact versus
the in-person
appointments

Successfully increased
access to care in rural areas.

psychotherapy. Palliative and Supportive
Care, 15(2), 176-180.
doi:10.1017/S1478951516000572

2

Reid, M., Krishnan, S., Berget, C., Cain, C., Thomas,
J., Klingensmith, G., & Raymond, J. (2018).
coyot1 clinic: home telemedicine increases
young adult engagement in diabetes care.
Diabetes Technology & Therapeutics, 20(5),
370-379.
http://doi.org/10.1089/dia.2017.0450

Cohort
Study

Setting: VirtualPrimary Care
Sample: 81
patients with
type 1 diabetes
(18–25 years of
age)

Appointments
were free
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3

Wadsworth, K. H., Archibald, T. G., Payne, A. E.,
Cleary, A. K., Haney, B. L., & Hoverman,

Systematic
Review

A. S. (2019). Shared medical appointments
and patient-centered experience: a mixed-

13 quantitative
controlled trials,
11 qualitative
papers, and two
mixed methods
studies

methods systematic review. BMC family
practice, 20(1), 97.

Improved patient trust,
quality of care, quality of
life, health outcomes, and
decreased health care costs.
Overall, attendance and
participation are significant
barriers in almost all studies
utilized in the systematic
review.

https://doi.org/10.1186/s12875-019-0972-1
4

Patel, T. A., Johnston, C. A., Cardenas, V. J., &
Vaughan, E. M. (2020). Utilizing

Cohort
Study

Telemedicine for Group Visit Provider
Encounters: A Feasibility and Acceptability

Setting: VirtualPrimary Care

Increased access to care and
attendance

Sample: 19
patients with
type 2 diabetes

Same improved outcomes
were noted in the face-toface appointments

A limited
number of
articles to review
due to specific
search

Level I

Inability to
double-blind
research
Sampling bias
may be noted in
some of the
reviewed articles
Not randomized

Level II

N/A

Level V

Study. International journal of diabetes &
metabolic syndrome, 1(1), 1–6.
5

Ramdas, K., Swaminathan, S. Patients could share

Editorial

N/A

virtual medical appointments for better
access to telemedicine. Nat Med 27, 14–16

Increase patient capacity for
self-care, compliance with
medications, engagement
with health care.

(2021). https://doi.org/10.1038/s41591-02001187-4
6

Childs, A., Bacon, S., Klingensmith, K., Li, L.,
Unger, A., Wing, A., & Fortunati, F. (2021).

Virtual SMAs created
greater access to
underprivileged populations.

Cohort
Study

Setting: Clinic,
Virtual: Mental
Health

Appointment attendance
increased for telehealth
versus in-person services for
adolescents (χ2

All markers of
acceptability or
outcomes were
not examined

Level II
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Showing up is half the battle: the impact of
telehealth on psychiatric appointment
attendance for hospital-based intensive
outpatient services during COVID-19.
Telemedicine and e-Health.835842.http://doi.org/10.1089/tmj.2021.0028

Sample: 869
patients

(df = 1) = 27.49, p < 0.0001)
and adults (χ2
(df = 1) = 434.37, p <
0.0001).
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Appendix B
Theoretical Model: Human Becoming Theory
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Appendix C
Participant Consent Form
Title of Study: The Effectiveness of a Virtual Shared Medical Appointment on Opioid
Safety Education Participation in the Veteran Population within a VA Health Care System
Principal Investigator: Jana Falkner, MSN, RN
This consent form is part of an informed consent process for a DNP student project, and it will
provide information that will help you decide whether you wish to volunteer for this project. It will
help you understand what the study is about and what will happen during the project. If you have
questions at any time during the project, you should feel free to ask them and should expect to be
given answers that you understand entirely. After all your questions have been answered, you may
complete the attached survey and participate in the educational sessions if you still wish to participate
in the project. You are not giving up any of your legal rights by volunteering for this research project.
Purpose of the project
Due to various barriers, including transportation, cost of travel, time, and the current COVID-19
pandemic, a decline in attendance and participation in the current face-to-face interdisciplinary Opioid
Safety Shared Medical Appointments (SMA) has been noted. With the opioid crisis rapidly growing,
opioid safety education is imperative to decrease opioid overdose and abuse. This DNP project aims to
increase accessibility to the interdisciplinary Opioid Safety SMA through a virtual platform. The study
will take place over 60 days and review three virtual SMAs (5 sessions each) and be compared to the
past practice of the face-to-face Opioid Safety SMAs to determine if the virtual platform increases
attendance and accessibility.
What will you be asked to do if you participate in this research project?
You will not be asked to do anything additional to the Opioid Safety SMA curriculum. You will be
provided with the equipment needed to participate in the virtual appointment, including a webcam.
Please know that participants are not required to enable or turn on their webcam, although
encouraged. A simple comparison of attendance will determine the outcomes of this project.
Participation in this project is of no cost to you.
How will information about you be kept private or confidential?
All efforts will be made to keep your personal information in your research record confidential, but
total confidentiality cannot be guaranteed. There will be no personal identifiers placed on the
attendance tracking spreadsheet. The spreadsheet will remain double locked (in a locked file cabinet
within a locked room) within the medical facility, and information will not be removed from the
premises.
As this is a group appointment, it is essential to realize that other patients, caregivers, and spouses will
hear the information that you share. Please understand that participants are not required to share any
information that they do not feel comfortable sharing in front of the group. Providers will not call on
any participants to provide information unless they are willing and volunteer the information. If
participants would like to participate in the group visit model but would like to ask a provider in a
private setting, a private room can be requested by the participant at the end of the virtual Opioid
Safety SMA through the course leader. Instructions will be shared on how to do this. Participants will
be informed as soon as they enter the room of the ground rules of the SMA, which include:
•

Participants are only required to share what they feel comfortable sharing
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•
•
•

Providers will not call on any patient for information. Patients will only share if they are
willing and volunteer the information.
Privacy and Confidentiality of the conversations that occur during the SMA do not leave the
room of the SMA
All participants and providers will let participants share without interruption

At this time, if the participant does not feel comfortable participating in the group visit model, they
will be provided the option to schedule a traditional provider appointment.
It is important to note that it will not be recorded although this session is virtual.
What will happen if you do not wish to participate in the project or if you later decide not to
stay in the project?
Participation in this project is voluntary. Suppose you do not want to enter the project or decide to
stop participating. You may choose not to participate, or you may change your mind at any time. You
may also withdraw your consent to use data already collected about you, but you must do this in
writing to Jana Falkner at jfalkner@stu.jsu.edu.
Who can you call if you have any questions?
If you have any questions about participating in this project, you can call the principal investigator:
Jana Falkner, MSN, RN, at jfalkner@stu.jsu.edu.
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AGREEMENT TO PARTICIPATE
Subject consent:
I have read this entire form, or it has been read to me, and I believe I understand what has
been discussed. All my questions about this form or this study have been answered. I
agree to take part in this research study.
Subject Name (printed name):
Signature:____________________________________ Date:________________
Signature of Investigator/Individual Obtaining Consent:
To the best of my ability, I have explained and discussed the study's complete contents,
including all of the information contained in this consent form. All questions of the
research subject and those of their parent or legally authorized representative have been
accurately answered.
Investigator/Person Obtaining Consent (printed name):
Signature:___________________________________________
Date:__________________
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Appendix D
Mobilize-Assess-Plan-Implement-Track (MAP-IT) framework

• Gain Buy-in: Meet with Exectuive Leadership Team and Whole Health Opioid
Safety Comittee to discuss project and potential cost-savings for the medical
Mobilize facility.

Assess

Plan

• Assess for resources needed to implement the project.
• Assess current curriculum to determine what needs to be converted for a virtual
learning environment.
• Develop a timeline for implementation including what needs to be done and who
will be responsible.
• For example: A patient workbook and kit will need to be mailed to the participants,
an agenda will need to be made.

• Once curriculum and agendas are created, the virtual shared medical
appointments can be scheduled for appropriate patients.
Implement • Chart reviews will be completed to determine attendance preimplementation.

Track

• Attendance and participation will be continuously tracked as the appointments are
occuring.
• After the virtual shared medical appointments have occured, a spreadsheet will be
utilized to compare and track attendance from both the face-to-face appointments
and the virtual appointments.
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Appendix E
DNP Timeline
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Appendix F
CITI Training Certificate
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Appendix G
University IRB Approval
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Appendix H
Budget

PROGRAM EXPENSE

Salaries, wages (Admin
support, practitioners,
statistics, or writing
consultation)

•
•
•
•
•
•

Training Costs
Travel Pay
Supplies
Total Project Expenses

FACE-TO-FACE SMA COST
Medical Doctor (MD)
$ 1,922.66
Pharmacist (PharmD)
$ 1,061.21
Dietician
$ 621.00
Registered Nurse (RN)
$ 561.82
Licensed Practical Nurse
(LPN) $ 387.03
Medical Service Assistant
(MSA) $ 337.09

$ 6,129.00
$5,805.00
$ 55.14
$ 16,879.94

•
•
•
•
•
•

VSMA COST
Medical Doctor (MD)
$ 1,922.66
Pharmacist (PharmD)
$ 1,061.21
Dietician
$ 621.00
Registered Nurse (RN)
$ 561.82
Licensed Practical Nurse
(LPN) $ 387.03
Medical Service Assistant
(MSA) $ 337.09

$ 6,129.00
$0

$ 805.14

$ 11,879.14
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Appendix I
Attendance Tracking

